retatrutide study news Today, we shared new data from the latest Phase 3 of retatrutide, an investigational treatment being studied for adults with obesity or overweight with at least one weight-related comorbidity. Learn more Retatrutide for weight loss: Study

Wensley had no interest in quitting an effective drug

All NMR spectra were phased and referenced to TSP in TopSpin 4.06 (Bruker BioSpin)

20 A large UK cohort (9 239 females, 556 males) found higher fracture risk in females across all ages (HR = 1.59) and in males over 40 (HR = 2.54), with hip/femur and pelvis most affected in females, vertebrae in males

Loyo, P

Research now indicates that GLP-1 receptor agonists, like Mounjaro, may be linked to a serious and potentially irreversible eye condition known as NAION

These are reasonable treatment options for chronic weight management, but they work in a fundamentally different (and more limited) way